Bipolar Tx Flashcards

1
Q

Mania

A

-abnormal elevates, expansive, irritable mood
-grandiosity, flight of ideas, distractibility, pressured speech, need for sleep, agitation, xs involvement in pleasurable activities
-hospitilization generally required
-severe episode may involve psychosis
-change in sleep pattern often initiate episodes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Bipolar disease course

A

-depression is the mood pole experienced most often (can lead to misdiagnoses)
-alc and substance use common (50-60%)
-anxiety disorders common comorbidity that can impact remission if untreated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Hypomania

A

-less severe form of mania
-hospitilization not required
-elevated, or irritable mood symptoms
-inflated self-esteem, dec need for sleep , distractibility
-no psychotic features

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Rapid-cycling

A

-4+ mood episodes in 1 year

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Bipolar I classification

A

-1+ MANIC episodes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Bipolar II classification

A

-HYPOmanic episodes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Bipolar Tx overview

A

-1st line: lithium or valproic acid (mood stabilizers)
-atypical antipsychotics may be used first line as mono or combo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Lithium

A

-NTI (make sure pt will not OD)
-associated w dec suicidiality
-1:1 conversion between citrate and carbonate forms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Lithium NTI dosing

A

-acute: 0.9-1.2 mEq/L
-maintenance: 0.6-0.9 mEq/L
-toxicity 1.5-3+
-draw trough serum concentration 72h after dose initiation, 12h after last dose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Lithium toxicity

A

-GI
-ataxia
-hand tremor
-altered mental status
-seizure
-lethargy, confusion, agitation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Lithium side effects

A

-hand tremor
-HYPOthyroidism
-polyuria/dipsia
-acne
-dry mouth
-weight gain
-ECG changes
-teatogenic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Lithium in pregnany

A

-AVOID in 1st trimester, caution 2nd and 3rd
-cardiac structural abnormality (Ebstein’s anomaly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Lithium monitoring

A

-SCr, BUN (renal)
-urine specific gravity
-Na, K, Ca
-ECG esp >40
-thyroid (TSH, T4)
-parathyroid hormone
-CBC w differential
-weight
-pregnancy test

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Lithium Drug Interactions

A

-dec Li renal cl (inc Li levels): ACE/ARBs, thiazides, NSAIDs, dehydration
-inc renal cl: caffeine, osmotic, loops
-inc excretion (dec levels): sodium bicarb, high Na intake
-toxicity related to Na depletion (thiazides)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Valproate dosing

A

-ER is 10-15% less bioavailable than delayed release
-1:1 conversion, lower concentration w ER (not that significant)
-syrup (IR) and capsule sprinkle form = higher GI ulceration (esophagus) risk
-serum levels 80-125mcg/ml associated w most efficacy in mania, obtain level at least 96h after first dose or dose inc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Valproic acid adverse effects

A

-GI: anorexia, N/V/D, dyspepsia, ulcers
-inc appetite/wt gain
-thrombocytopenia, platelet dysfunction
-hyperammonemia
-teratogenic
-PCOS

17
Q

Valporic acid in pregnancy

A

-AVOID
-obtain baseline pregnancy test

18
Q

Valproic acid PCOS

A

-upto 50% of women
-assess menstrual cycle

19
Q

Valproate monitoring

A

-baseline: preg, LFTs, CBC
-serum ammonia only if suspected

20
Q

Valproate drug interactions

A

-sig concern w combo ise w lamotrigine (inc lamotrigine = inc SJS risk)
-many interactions

21
Q

Other mood stabilizers

A

-carbamazepine
-oxcarbamazepine
-lamotrigine
-topiramate

22
Q

Carbamazepine

A

-CYP450 inducer, auto-induction of metabolism
-steady state 14 days
-thrombocytopenia/hematologic effects

23
Q

oxcarbamazepine

A

-CYP450 3A4 inducer (no auto-induction)
-hyponatremia but less hematologic effects compared to carbamazepine

24
Q

Lamotrigine

A

-1st line for DEPRESSIVE sx in bipolar
-NOT useful for mania

25
Q

Lamotrigine dose titration

A

-go to seizure notes

26
Q

Topiramate

A

-may cause wt loss
-heat intolerance/oligohidrosis
-metabolic acidosis and kidney stones
-possible teratogen (cardiac structural defects)

27
Q

Antipsychotics in bipolar

A

-NOT brexpiprazole, clozapine, iloperidone, paliperidone
-can use as monotherapy or combo
-all monitoring parameters for metabolic disorder and movement side effects

28
Q

Bipolar treatment considerations

A

-mood stabilizer tx long-term and considered to be maintenance tx to reduce time between episodes
-suicide attempt risk is high in both poles, monitor closely, use lithium cautiously

29
Q

Bipolar treatment during pregnancy

A

-AVOID lithium, valproate, carbamazepine, topiramate

30
Q

Antidepressants in bipolar

A

-linked to switch to mania
-need to have maintenance mood stabilizer in combo w antidepressant tx
-use SSRI/SNRI for anxiety
-prefer to use mood stabilizers that target depressive pole (lamotrigine, lithium, lurasidone, quetiapine)